arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Novo Nordisk A/S

NVO Health Care Biotechnology: Pharmaceutical Preparations
$44.58
▲ +0.2% Today
as of Aug 5, 16:52 ET
Last 30 days -7.36% Jun 26 → Aug 05
$43.69 $45.82 $47.94 $50.07 $52.20 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$44.05
High
$44.22
Low
$42.85
Volume
$11M
Avg Vol
$18M
Mkt Cap
$208.5B
P/E (TTM)
—
Beta
—
52w High
$81.44
52w Low
$35.12
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 25 ▼ 0
Aug 5 · 07:23 Investing.com neutral
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
Aug 4 · 21:27 Investor's Business Daily neutral
Novo Nordisk Stock Stumbles On A Key Miss As Its Battle With Eli Lilly Heats Up
Aug 4 · 21:25 Barrons.com neutral
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$35
$81
20% of range
Avg surprise (last 3)
+7.9%
Avg reaction (last 2)
+1.9%
100% positive
Latest IV / EM
39%
EM ±2.3% · $45 · Aug 7

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.87$0.91$0.96$1.00$1.04 Actual $0.92Est $0.92Actual $0.97Est $0.93Actual $1.04Est $0.87 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $1.04 $0.87 +19.5% +13.0% +2.0% earnings
Wed Aug 6, 2025Jun/2025 $0.97 $0.93 +4.3% — — earnings
Wed May 7, 2025Mar/2025 $0.92 $0.92 0.0% — +1.9% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 5, 2026Jun/2026OTHER $0.81$0.97 -16.5%

Implied volatility — last 90 days

34%45%56%67%78% Jun 07 — IV 47% · EM ±4.4%Jun 08 — IV 47% · EM ±3.9%Jun 09 — IV 45% · EM ±3.2%Jun 10 — IV 47% · EM ±2.8%Jun 11 — IV 46% · EM ±1.9%Jun 15 — IV 42% · EM ±3.0%Jun 16 — IV 41% · EM ±2.4%Jun 17 — IV 42% · EM ±1.7%Jun 19 — IV 36% · EM ±3.9%Jun 22 — IV 43% · EM ±3.6%Jun 23 — IV 46% · EM ±3.4%Jun 24 — IV 44% · EM ±2.6%Jun 25 — IV 45% · EM ±1.9%Jun 29 — IV 38% · EM ±9.0%Jun 30 — IV 37% · EM ±8.6%Jul 01 — IV 40% · EM ±1.7%Jul 03 — IV 38% · EM ±4.3%Jul 06 — IV 42% · EM ±3.5%Jul 07 — IV 41% · EM ±3.0%Jul 08 — IV 38% · EM ±2.2%Jul 09 — IV 34% · EM ±1.4%Jul 13 — IV 41% · EM ±3.4%Jul 14 — IV 42% · EM ±3.0%Jul 15 — IV 43% · EM ±2.6%Jul 16 — IV 46% · EM ±1.9%Jul 20 — IV 40% · EM ±3.3%Jul 21 — IV 40% · EM ±2.9%Jul 22 — IV 45% · EM ±2.6%Jul 23 — IV 55% · EM ±2.3%Jul 27 — IV 42% · EM ±3.5%Jul 28 — IV 52% · EM ±3.7%Jul 29 — IV 55% · EM ±3.2%Jul 30 — IV 69% · EM ±2.9%Aug 03 — IV 78% · EM ±6.5%Aug 04 — IV 54% · EM ±3.9%Aug 05 — IV 39% · EM ±2.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in